Why Bruker Stock Slumped Monday
(NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the closing bell, as investors didn't take kindly to a double miss on full-year guidance. Earlier in the trading session, Bruker dipped as much as 3.9%.
Bruker, which specializes in the supply of medical devices and scientific instruments, earned revenue of almost $861 million in its third quarter. This number was down 0.5% from the same period of 2024.
Image source: Getty Images.
Source Fool.com
Bruker Corp. Aktie
38,16 €
-0,34 %
Mehrere Buy-Einschätzungen dominieren bei Bruker Corp. ohne Sell-Gegenstimmen.
Ein Kursziel von 46 € für Bruker Corp. könnte zu einer Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 38.16 € führen.
